Search clinical trials for: pharmorubicin or pirarubicin

Total 5751 results

Xuesong Li

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

Upper Tract Urothelial Carcinoma | Bladder Recurrence
RenJi Hospital
Shanghai Pudong Hospital; Shanghai Pudong New Area Gongli Hospital

Unknown

Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma

Intravesical Instillation

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Triple Negative Breast Cancer

China
Peking University First Hospital

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

Upper Tract Urothelial Carcinoma | Bladder Recurrence

China
Asan Medical Center

Completed

Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer (Neo-shorter)

Breast Cancer

Korea, Republic of
Peking University First Hospital

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

Upper Tract Urothelial Carcinoma | Bladder Recurrence | Nephroureterectomy

China
Amgen

Terminated

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma (RILOMET-1)

Gastric Cancer

United States, Italy, Belgium, Hungary, Poland, Romania, Denmark, Switzerland, Canada, France, Germany, Russian Federation, Turkey, United Kingdom, Spain, Austria, Portugal, Australia, Greece, South Africa, Bulgaria, Ukraine, Brazil, ... and more
Tianjin Medical University Cancer Institute and...

Unknown

Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma

Soft Tissue Sarcoma

China
Sun Yat-sen University

Unknown

Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Shengjing Hospital

Not yet recruiting

Combination Therapy of Anthracyclines for Children With Nephroblastoma

0.5-14 Year Old Children With Nephroblastoma

China
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-75276617 in Combination With Acute Myeloid Leukemia (AML) Directed Therapies

Leukemia, Myeloid, Acute

United States, Germany, Italy, France, Australia, Spain, United Kingdom
Peking University People's Hospital
Xijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaborators

Withdrawn

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma (PDVPSTS)

Toxicity | Overall Survival | Progression-free Survival

China
University of Colorado, Denver

Completed

Phase II Trial for Large ER-Negative Breast Cancers

Malignant Neoplasm of Female Breast

United States
Novartis Pharmaceuticals

Completed

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.

Acute Myeloid Leukemia

Italy, Croatia, Estonia, Czechia, France, Spain, Sweden, Bulgaria, Lithuania, Serbia, Hungary, Finland, Norway, Romania, Slovakia
Hospital Ambroise Paré Paris

Completed

Comparison of the Efficacy of rTMS and tDCS of the Motor Cortex in Patients With Chronic Neuropathic Pain

Lumbar Radiculopathy

France
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy

Korea, Republic of
Kangpu Biopharmaceuticals, Ltd.

Completed

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

Castration-Resistant Prostate Cancer

United States
Ming Zhao

Unknown

Combine TACE and RFA Versus TACE Alone for HCC With PVTT (CORTT)

Hepatocellular Carcinoma

China
The Affiliated Hospital of the Chinese Academy...

Unknown

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
University of Nottingham
University of Wisconsin, Madison

Completed

Factors Associated With Perioperative Outcomes in Non-emergency Surgery

Stroke | Pneumonia | Acute Coronary Syndrome
Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaborators

Unknown

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Acute Promyelocytic Leukemia

China
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A First-in-Human Study of QY211 Gel in Adult Subjects

Atopic Dermatitis

China
HK inno.N Corporation

Unknown

A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

Healthy

Korea, Republic of
Arthrosi Therapeutics

Completed

Multiple Ascending Dose Study of AR882 in Healthy Adult Male Volunteers

Healthy Volunteers

Australia
Biotronik SE & Co. KG

Completed

TD01 Master Study (Safety and Efficacy Study)

ICD/CRT-D Indication

Germany, Austria
Christian Ruff

Not yet recruiting

Brain Network Mechanisms Causally Underlying Human Decisions Revealed by Brain Stimulation and Functional MRI

Behavior and Behavior Mechanisms
Bastyr University

Recruiting

Biological and Psychological Health Effect of Ramadan Study (HERS)

Quality of Life

United States
Clavis Pharma
Syneos Health; Theradex

Completed

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Acute Myeloid Leukemia

United States, Norway, Germany, France
Huabo Biopharm Co., Ltd.

Completed

A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

China
Jinling Hospital, China

Active, not recruiting

Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients (SVOSA)

Stomach Neoplasms | Gastric Cancer

China
Intron Biotechnology, Inc.

Completed

A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011

Acute Radiation Syndrome

Korea, Republic of
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

European Multicenter Study on Surgical Management of Advanced Thyroid Cancer (ATCEU)

Thyroid Neoplasms | Thyroid Cancer, Papillary | Thyroid Cancer, Follicular | Thyroid Carcinoma | Thyroid Cancer | Anaplastic Thyroid Cancer | Thyroid Medullary Carcinoma

Italy
Sun Yat-sen University

Not yet recruiting

Combination of Local Therapy and Target Therapy for Brain Metastases With EGFR Mutation (CLTBME)

Brain Metastases
Pfizer

Terminated

A Single Dose Study Of PF-06291874 In Healthy Adult Subjects

Healthy

United States
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Stage IV (Oligo-metastases)

Netherlands
Centre Hospitalier Universitaire de Besancon

Recruiting

Pilot Study to Validate ex Vivo Expression of Specific Biomarkers of Human Resolutive Macrophages (RESOMACRO)

Inflammation

France
JW Pharmaceutical

Completed

This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction. (SPEED)

Erectile Dysfunction

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects

Healthy

United States
Creabilis SA
LCG Bioscience

Completed

A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers

Safety
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
Zhongda Hospital

Recruiting

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
University of Toronto
University of Saskatchewan; Saskatchewan Food Industry Development Center

Recruiting

Impact of Pea, Lentil and Oat Flour Particle Size on Glycemic Response in Healthy Adults (PLO)

Obesity | Malnutrition; Diabetes | Malnutrition; Protein

Canada
Yonsei University

Completed

Docetaxel and Epirubicin in Advanced Gastric Cancer

Stomach Neoplasms

Korea, Republic of
University Hospital, Montpellier
Guerbet

Recruiting

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion (LIDA-BII)

Carcinoma, Hepatocellular

France
Federation Francophone de Cancerologie Digestive

Completed

Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II (IDASPHERE II)

Liver Cancer

France
Ji Xing Pharmaceuticals Australia Pty Ltd
Novotech (Australia) Pty Limited

Recruiting

JX09 SAD/MAD in Healthy Participants

Resistant Hypertension

Australia
Targeted Medical Education

Unknown

TME Neoadjuvant Breast Registry

Breast Cancer | Breast Neoplasms

United States
Sixth Affiliated Hospital, Sun Yat-sen University
Nanfang Hospital of Southern Medical University

Not yet recruiting

Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer (ARF-RC)

Rectal Cancer
Endo Pharmaceuticals

Completed

Vantas Implant Retrieval Study

Prostate Cancer
Stanford University

Completed

Evaluation of Inpatient Sleep and Activity Following Childbirth

Sleep

United States

Search clinical trials for: pharmorubicin or pirarubicin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations